RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: The gender- and age-dependency of the risk for Alzheimer's disease conferred by apolipoprotein E polymorphism in Koreans

Psychiatry Investig 1(1):56-60 · 2004

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

6,514편 검색→1,976편 판독→207편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Age and sex modification of apolipoprotein E epsilon4 associated Alzheimer disease risk (apolipoprotein E4 OR APOE4 OR "apolipoprotein E epsilon 4" OR "APOE ε4" OR "APOE e4" OR ApoE4 OR "apolipoprotein E*4") AND (Alzheimer*[tiab] OR "Alzheimer disease"[MeSH Terms] OR "Alzheimer's disease"[tiab] OR dementia[tiab]) AND (age[tiab] OR aged[tiab] OR "age of onset"[tiab] OR ageing[tiab] OR aging[tiab] OR sex[tiab] OR gender[tiab] OR "sex differences"[tiab] OR women[tiab] OR men[tiab] OR "sex factors"[MeSH Terms])

출판 연도

2022: 1편120222023: 46편462024: 43편432025: 58편582026: 59편592026

선별된 207편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01cognitive · memory48편

  1. 0.96

    Age and sex differences in the association between APOE genotype and Alzheimer's disease in a Taiwan Chinese population

    Huang LC, Lee MY, Chien CF et al. · Frontiers in aging neuroscience · 2023

  2. 0.91

    Effect of apolipoprotein E epsilon4 and its modification by sociodemographic characteristics on cognitive measures in South Asians from LASI-DAD

    Wang YZ, Zhao W, Moorjani P et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  3. 0.91

    TOMM40 and APOC1 variants differentiate the impacts of the APOE epsilon4 allele on Alzheimer's disease risk across sexes, ages, and ancestries

    Kulminski AM, Jain-Washburn E, Philipp I et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  4. 0.83

    APOE epsilon4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD

    Polsinelli AJ, Lane KA, Manchella MK et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  5. 0.82

    Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults

    Walters S, Contreras AG, Eissman JM et al. · JAMA neurology · 2023

  6. 0.82

    Sex Differences in Amyloid Pathology by Race, Ancestry, and Apolipoprotein E epsilon4 in an Admixed Autopsy Sample

    Abu Raya M, Suemoto CK, Paes VR et al. · JAMA neurology · 2026

  7. 0.80

    Association of APOE epsilon4 Status With Long-term Declines in Odor Sensitivity, Odor Identification, and Cognition in Older US Adults

    GoodSmith MS, Wroblewski KE, Schumm LP et al. · Neurology · 2023

  8. 0.77

    Effect sizes of APOE e4 on the same general cognitive ability test taken by the same people from age 11 to age 90: The Lothian Birth Cohorts 1921 and 1936

    Deary I, Harris S, Russ T et al. · Research square · 2025

  9. 0.77

    Sex differences in interacting genetic and functional connectivity biomarkers in Alzheimer's disease

    Williamson JN, James SA, Mullen SP et al. · GeroScience · 2024

  10. 0.74

    Sex moderates apolipoprotein E epsilon4 effects on sleep expression and memory retention

    Sattari N, Dave A, Chen IY et al. · medRxiv : the preprint server for health sciences · 2026

  11. 0.72

    Evidence of APOE4-related brain vulnerabilities in verbal memory systems in midlife women

    Wugalter KA, Thurston RC, Wu M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  12. 0.71

    Female APOE varepsilon4 Carriers with Slow Rates of Biological Aging Have Better Memory Performances Compared to Female varepsilon4 Carriers with Accelerated Aging

    O'Shea DM, Galvin JE · Journal of Alzheimer's disease : JAD · 2023

  13. 0.70

    Understanding the interplay between APO E polymorphism and cognition in the Italian oldest old: results from the "Mugello study"

    Lombardi G, Pancani S, Bagnoli S et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024

  14. 0.70

    APOE epsilon4 and Accelerated Cognitive Decline Among Cognitively Healthy Middle-Aged and Older Adults

    Chung YCE, Chung RH, Hsu CC et al. · JAMA network open · 2026

  15. 0.69

    Apolipoprotein E (APOE) and Alzheimer's disease risk in a Ugandan population: A pilot case-control study

    Lwere K, Muwonge H, Sendagire H et al. · Medicine · 2025

  16. 0.69

    Association between ApoE epsilon4 genotype and attentional function in non-demented, middle-aged, and older adults from rural India

    Rai P, Sundarakumar JS, Basavaraju N et al. · Journal of neurosciences in rural practice · 2024

  17. 0.68

    Sex differences in genetic modifiers of traumatic brain injury and late-life cognitive decline: the Cache County study

    Drewel MA, Schwartz S, Rattinger GB et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026

  18. 0.67

    Effect sizes of APOE e4 on the same general cognitive ability test taken by the same people from age 11 to age 90: The Lothian Birth Cohorts 1921 and 1936

    Deary IJ, Harris SE, Russ TC et al. · Molecular psychiatry · 2026

  19. 0.66

    Older adults at greater risk for Alzheimer's disease show stronger associations between sleep apnea severity in REM sleep and verbal memory

    Lui KK, Dave A, Sprecher KE et al. · Alzheimer's research & therapy · 2024

  20. 0.66

    Elevated gonadotropins and risk of dementia in Chinese adults aged over 80: a cross-sectional study

    Zhu Y, Tu Y, Ren C et al. · Frontiers in aging neuroscience · 2025

  21. 0.65

    Walking to protect against cognitive decline: the role of APOE genotype and sex

    Burma JS, Rosano C, Best JR et al. · Biology of sex differences · 2026

  22. 0.65

    Sex-Specific Entorhinal Cortex Functional Connectivity in Cognitively Normal Older Adults with Amyloid-beta Pathology

    Gong L, Liu D, Zhang B et al. · Molecular neurobiology · 2025

  23. 0.64

    Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort

    Vasiljevic E, Koscik RL, Jonaitis E et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  24. 0.63

    Associations between sex and lifestyle activities with cognitive reserve in mid-life adults with genetic risk for Alzheimer's disease

    Qi Q, Deng F, Sammon R et al. · Alzheimer's research & therapy · 2024

  25. 0.61

    Genetic and Hormonal Contributions to Psychosis Symptoms in Alzheimer's Disease: A Sex-Stratified Analysis

    Rajkumar G, Uthayakumar H, Khoury MA et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2026

  26. 0.60

    Clinical and neuropsychological profile of Alzheimer's disease in Tunisia and the impact of APOE gene

    Gharbi A, Sghaier I, El Habibi M et al. · Frontiers in genetics · 2026

  27. 0.59

    Sex differences in sleep and memory relationships in older adults at risk for Alzheimer's disease

    Sattari N, Dave A, Chen IY et al. · Frontiers in endocrinology · 2026

  28. 0.59

    Cerebellar EEG source localization reveals age-related compensatory activity moderated by genetic risk for Alzheimer's disease

    Paitel ER, Nielson KA · Psychophysiology · 2023

  29. 0.58

    Psychiatric symptoms and alzheimer's disease: Depression-anxiety comorbidity effects and their neurobiological mediating mechanisms

    Yang J, Xue W, Zheng W et al. · Journal of affective disorders · 2026

  30. 0.58

    Sex differences in APOE- and PICALM-related cognitive profiles in healthy middle-aged adults

    Bednorz A, Trybek P, Hoang MT et al. · Frontiers in aging · 2025

  31. 0.58

    Clinical and demographic factors modify the association between plasma phosphorylated tau-181 and cognition

    Bolton CJ, Steinbach M, Khan OA et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  32. 0.58

    Exploring sex-specific risk factors in cognitive decline: Insights into modifiable and non-modifiable determinants using a network analysis

    Intzandt B, Ramirez J, Lam B et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  33. 0.57

    Sex Differences in Dementia, Cognition, and Health in the Cognitive Function and Ageing Studies (CFAS)

    Merrick R, Brayne C · Journal of Alzheimer's disease : JAD · 2024

  34. 0.57

    Longitudinal excitation-inhibition balance altered by sex and APOE-epsilon4

    Burns AP, Fortel I, Zhan L et al. · Communications biology · 2025

  35. 0.57

    Persistent financial adversity and cognitive aging: a life course investigation

    Liu Y, Wels J, James SN et al. · Innovation in aging · 2026

  36. 0.56

    Low testosterone levels relate to poorer cognitive function in women in an APOE-epsilon4-dependant manner

    Dratva MA, Banks SJ, Panizzon MS et al. · Biology of sex differences · 2024

  37. 0.56

    Obstructive sleep apnoea and 5-year cognitive decline in the elderly

    Marchi NA, Solelhac G, Berger M et al. · The European respiratory journal · 2023

  38. 0.56

    Association between physical activity and episodic memory and the moderating effects of the apolipoprotein E epsilon4 allele and age

    Lee BC, Choe YM, Suh GH et al. · Frontiers in aging neuroscience · 2023

  39. 0.55

    Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort

    Saleh RNM, Hornberger M, Ritchie CW et al. · Alzheimer's research & therapy · 2023

  40. 0.55

    Body Circumference and Cognitive Function: Role of Apolipoprotein E epsilon4 in the Elderly

    Kim JH, Choe YM, Choi HJ et al. · International journal of molecular sciences · 2025

  41. 0.54

    Older adults at greater risk for Alzheimer's disease show stronger associations between sleep apnea severity and verbal memory

    Lui K, Dave A, Sprecher K et al. · Research square · 2023

  42. 0.53

    Functional network centrality indicates interactions between APOE4 and age across the clinical spectrum of Alzheimer's Disease

    Fall AB, Preti MG, Eshmawey M et al. · NeuroImage. Clinical · 2024

  43. 0.52

    Gender specific factors contributing to cognitive resilience in APOE varepsilon4 positive older adults in a population-based sample

    Zheng L, Eramudugolla R, Cherbuin N et al. · Scientific reports · 2023

  44. 0.52

    Role of APOE varepsilon4 and varepsilon2 With Longitudinal Cognitive Decline Among Those With Exceptional Longevity: The LifeAfter90 Study

    Colbeth HL, Posis AIB, Rizvi BM et al. · Neurology · 2026

  45. 0.52

    Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years

    Najar J, Thorvaldsson V, Kern S et al. · Neurobiology of disease · 2023

  46. 0.51

    Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease

    Ukraintseva S, Duan H, Holmes R et al. · Journal of Alzheimer's disease : JAD · 2024

  47. 0.51

    Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function

    Xu Y, Sun Z, Jonaitis E et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  48. 0.50

    The Relationship Between Physical Activity and Non-Modifiable Risk Factors on Alzheimer's Disease and Brain Health Markers: A UK Biobank Study

    Spencer FSE, Elsworthy RJ, Breen L et al. · Journal of Alzheimer's disease : JAD · 2024

02white matter · volume46편

  1. 0.86

    Impact of sex and APOE-epsilon4 genotype on patterns of regional brain atrophy in Alzheimer's disease and healthy aging

    Sauty B, Durrleman S · Frontiers in neurology · 2023

  2. 0.86

    Accelerated hippocampal atrophy in APOE epsilon4 homozygotes and females: Longitudinal findings from the Tohoku Medical Megabank MRI study

    Mugikura S, Mori N, Satake M et al. · Neuroradiology · 2026

  3. 0.84

    Longitudinal effects of sex differences and apolipoprotein E genotype on white matter engagement among elderly

    Zhang H, Zhang J, Hsu CL et al. · Brain communications · 2025

  4. 0.83

    Age at menopause, APOE-epsilon4, and Alzheimer's disease risk

    Wood Alexander M, Nyman AJ, Casaletto KB et al. · Research square · 2026

  5. 0.82

    Effects of sex and APOE epsilon4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer's disease: A 31Phosphorus MR spectroscopy study

    Jett S, Dyke JP, Boneu Yepez C et al. · PloS one · 2023

  6. 0.81

    Disrupted excitation-inhibition balance in cognitively normal individuals at risk of Alzheimer's disease

    Fortel I, Zhan L, Ajilore O et al. · bioRxiv : the preprint server for biology · 2023

  7. 0.81

    APOE epsilon4-associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum

    Mares J, Kumar G, Sharma A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  8. 0.81

    Sex Differences in Alzheimer Disease Imaging Biomarkers in a Diverse, Community-Based Cohort

    Akinci M, Aziz F, Palta P et al. · JAMA network open · 2026

  9. 0.80

    Sex-Specific Structural Vulnerability in Alzheimer's Disease: Insights from APOE epsilon 4-Negative Patients

    Michelin W, Pinto JO, Peixoto B · Life (Basel, Switzerland) · 2026

  10. 0.76

    Effect of APOE4 Allele and Gender on the Rate of Atrophy in the Hippocampus, Entorhinal Cortex, and Fusiform Gyrus in Alzheimer's Disease

    Hamza EA, Moustafa AA, Tindle R et al. · Current Alzheimer research · 2022

  11. 0.74

    A comprehensive analysis of APOE genotype effects on human brain structure in the UK Biobank

    Heise V, Offer A, Whiteley W et al. · Translational psychiatry · 2024

  12. 0.73

    Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank

    Ambikairajah A, Khondoker M, Morris E et al. · Human brain mapping · 2024

  13. 0.72

    APOE4 and Chronic Health Risk Factors are Associated with Sex-Specific Preclinical Alzheimer's Disease Neuroimaging Biomarkers

    Losinski GM, Key MN, Vidoni ED et al. · medRxiv : the preprint server for health sciences · 2024

  14. 0.72

    APOE varepsilon4 exacerbates age-dependent deficits in cortical microstructure

    Mak E, Dounavi ME, Operto G et al. · Brain communications · 2024

  15. 0.71

    APOE4-related differences in cortical thickness are modulated by sex in middle age

    Leclaire KN, Blujus JK, Korthauer LE et al. · Brain imaging and behavior · 2024

  16. 0.70

    The CSF p-tau/beta-amyloid 42 ratio correlates with brain structure and fibrillary beta-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease

    Cacciaglia R, Shekari M, Salvado G et al. · Brain communications · 2025

  17. 0.70

    Sex and APOE genotype specific brain regional vulnerability to Alzheimer's Disease

    Zeng Q, Wang M, Wang E et al. · GeroScience · 2026

  18. 0.69

    Texture-based morphometry in relation to apolipoprotein epsilon4 genotype, ageing and sex in a midlife population

    Dounavi ME, Mak E, Operto G et al. · Human brain mapping · 2024

  19. 0.69

    Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status

    Reas ET, Triebswetter C, Banks SJ et al. · Alzheimer's research & therapy · 2024

  20. 0.66

    Respective influence of beta-amyloid and APOE epsilon4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults

    de Flores R, Demeilliez-Servouin S, Kuhn E et al. · Neurobiology of disease · 2023

  21. 0.65

    Sex Differences in Cortical Thickness and Neuropsychiatric Symptom Burden Based on APOE4 Homozygosity in Alzheimer's Disease

    Khoury MA, Valcic M, Churchill NW et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2025

  22. 0.65

    Predicting longitudinal basal forebrain volume in the Alzheimer's disease spectrum: the role of sex and ApoE epsilon 4 genotype

    Grazia A, Levin F, Jessen F et al. · Frontiers in neuroscience · 2026

  23. 0.65

    Estradiol and memory circuitry in the postmenopause: Modification by APOE4

    Schroeder RA, Thurston RC, Wu M et al. · Research square · 2026

  24. 0.64

    APOE4 and chronic health risk factors are associated with sex-specific preclinical Alzheimer's disease neuroimaging biomarkers

    Losinski GM, Key MN, Vidoni ED et al. · Frontiers in global women's health · 2025

  25. 0.64

    The characteristics of brain atrophy prior to the onset of Alzheimer's disease: a longitudinal study

    Hu Y, Zhu T, Zhang W · Frontiers in aging neuroscience · 2024

  26. 0.63

    Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History study

    Pieperhoff L, Lorenzini L, Mastenbroek S et al. · NeuroImage. Clinical · 2025

  27. 0.62

    Hippocampal mediation in the lipid-Alzheimer's disease pathway: A high-dimensional mediation analysis stratified by APOE and sex

    Cao Y, Fan Y, Meng Q et al. · Alzheimer's & dementia (New York, N. Y.) · 2026

  28. 0.59

    Increased vulnerability to low-density lipoprotein cholesterol in apolipoprotein E4-positive females: Longitudinal effects on neurodegeneration and cognition

    Tayem AJ, Jaber AB, Altantawi AM et al. · Journal of Alzheimer's disease : JAD · 2026

  29. 0.59

    Reproductive lifespan and hormonal therapy in relation to later-life neurovascular health: A population-based study of women in the Gothenburg H70-1944 Birth Cohort

    Lorenzon G, Garcia-Lluch G, Coughlan G et al. · medRxiv : the preprint server for health sciences · 2026

  30. 0.59

    The interaction effects of age, APOE and common environmental risk factors on human brain structure

    Chen J, Li T, Zhao B et al. · Cerebral cortex (New York, N.Y. : 1991) · 2024

  31. 0.59

    Midlife brain vulnerability: Sex differences in functional magnetic resonance imaging and Alzheimer's disease risk

    Alshaheri Durazo A, McDonough IM · Journal of Alzheimer's disease : JAD · 2026

  32. 0.57

    Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults

    Soldan A, Wang J, Pettigrew C et al. · Brain communications · 2024

  33. 0.57

    The Differential Effects of APOEvarepsilon4 on Cerebral Volumetric Structures in Different Lifespan in Community-Dwelling Populations

    Tang M, Su N, Zhang D et al. · Journal of Alzheimer's disease : JAD · 2023

  34. 0.56

    Associations of endogenous estrogens, plasma Alzheimer's disease biomarkers, and APOE4 carrier status on regional brain volumes in postmenopausal women

    Wugalter KA, Schroeder RA, Thurston RC et al. · Frontiers in aging neuroscience · 2024

  35. 0.55

    Lifestyle for Brain health (LIBRA) score, cognition, brain volume, and dementia risk in the UK Biobank

    Sewell KR, Doecke JD, Gardener SL et al. · GeroScience · 2026

  36. 0.55

    Adherence to Life's Essential 8 is associated with delayed white matter aging

    Feng L, Ye Z, Pan Y et al. · medRxiv : the preprint server for health sciences · 2024

  37. 0.55

    Vulnerability to memory decline in aging - a mega-analysis of structural brain change

    Vidal-Pineiro D, Sorensen O, Stromstrad M et al. · bioRxiv : the preprint server for biology · 2025

  38. 0.54

    Association of neighborhood deprivation with Alzheimer's Disease pathology, brain structure, and cognition by race and ethnicity, sex, and APOE epsilon4 status

    Aguilar-Dominguez P, Colceriu CM, Holland TM et al. · medRxiv : the preprint server for health sciences · 2026

  39. 0.54

    Impact of age and apolipoprotein E epsilon4 status on regional white matter hyperintensity volume and cognition in healthy aging

    Van Etten EJ, Bharadwaj PK, Grilli MD et al. · Journal of the International Neuropsychological Society : JINS · 2024

  40. 0.54

    Traffic-related air pollution and APOE4 can synergistically affect hippocampal volume in older women: new findings from UK Biobank

    Popov VA, Ukraintseva SV, Duan H et al. · Frontiers in dementia · 2024

  41. 0.52

    Associations between accelerometer-measured circadian rest-activity rhythm, brain structural and genetic mechanisms, and dementia

    Liu Y, Feng H, Du J et al. · Psychiatry and clinical neurosciences · 2024

  42. 0.52

    Associations of [(18)F]PI-2620 Binding with Memory and Phosphorylated Tau 217 in Cognitively Unimpaired Older Adults

    Maass A, Garcia-Garcia B, Behrenbruch N et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026

  43. 0.51

    Blood-brain barrier permeability varies by brain region and APOE4 status and correlates with brain microstructure among high-AD risk groups

    Solders SK, Shen Q, Reas ET · NeuroImage. Clinical · 2025

  44. 0.50

    Lifespan reference curves for harmonizing multi-site regional brain white matter metrics from diffusion MRI

    Zhu AH, Nir TM, Javid S et al. · bioRxiv : the preprint server for biology · 2024

  45. 0.50

    Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis

    Bocancea DI, Svenningsson AL, van Loenhoud AC et al. · Brain : a journal of neurology · 2023

  46. 0.50

    Sex, racial, and APOE-epsilon4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer's disease

    Peterson A, Sathe A, Zaras D et al. · bioRxiv : the preprint server for biology · 2024

03amyloid · pet32편

  1. 0.92

    The Effect of Gender and APOE varepsilon4 Status on Brain Amyloid-beta Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study

    Wang J, Wang M, Ren S et al. · Journal of Alzheimer's disease : JAD · 2023

  2. 0.89

    The time interval from amyloid to tau PET positivity varies by age, sex and APOE-epsilon4 status

    Mila-Aloma M, Hausle I, Petersen KK et al. · The journal of prevention of Alzheimer's disease · 2026

  3. 0.87

    18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population

    Zhao Z, Wang J, Wang Y et al. · Journal of Alzheimer's disease : JAD · 2023

  4. 0.84

    Temporal sequence of amyloid and tau PET positivity: APOE -epsilon4 and sex effects, and implications for Alzheimer's disease progression

    Mila-Aloma M, Hausle I, Petersen KK et al. · medRxiv : the preprint server for health sciences · 2025

  5. 0.83

    Variable and interactive effects of Sex, APOE epsilon4 and TREM2 on the deposition of tau in entorhinal and neocortical regions

    Giorgio J, Jonson C, Wang Y et al. · Nature communications · 2025

  6. 0.81

    Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-beta status, APOE genotype and sex

    Ossenkoppele R, Coomans EM, Apostolova LG et al. · Nature neuroscience · 2025

  7. 0.80

    Sex and APOE epsilon4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease

    Nemes S, Logan PE, Manchella MK et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  8. 0.77

    Age-dependent interactions of APOE isoform 4 and Alzheimer's disease neuropathology: findings from the NACC

    Hayes CA, Thorpe RJJ, Odden MC · Acta neuropathologica communications · 2025

  9. 0.76

    Sex and APOE genotype differences in amyloid deposition and cognitive performance along the Alzheimer's Continuum

    Pan F, Wang Y, Wang Y et al. · Neurobiology of aging · 2023

  10. 0.75

    Associations of cerebral amyloid beta and tau with cognition from midlife

    Gonzales MM, O'Donnell A, Ghosh S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  11. 0.74

    Factors associated with age at tau pathology onset and time from tau onset to dementia

    Heston MB, Teague JP, Cody KA et al. · medRxiv : the preprint server for health sciences · 2025

  12. 0.74

    Sex differences in the impact of genetic and clinical risk factors for Alzheimer's disease in midlife

    Konishi K, Spets DS, Fisher P et al. · Journal of Alzheimer's disease : JAD · 2025

  13. 0.70

    Brain tau PET-based identification and characterization of subpopulations in patients with Alzheimer's disease using deep learning-derived saliency maps

    Li Y, Wang X, Ge Q et al. · EJNMMI physics · 2025

  14. 0.69

    Lifetime and 10-year absolute risk of cognitive impairment in relation to amyloid PET severity: a retrospective, longitudinal cohort study

    Jack CRJ, Hu M, Wiste HJ et al. · The Lancet. Neurology · 2025

  15. 0.67

    Global and regional amyloid-beta in explaining APOE-epsilon4 and sex associations with medial temporal tau: a neuropathology study

    Salvado G, Groot C, Wisse LE et al. · Acta neuropathologica · 2026

  16. 0.67

    Age-related amyloid beta dynamics modeled with the generalized additive model for location, scale, and shape (GAMLSS) across diverse populations: Cross-sectional trajectories and longitudinal validation

    Lee S, Chun MY, Jang H et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  17. 0.63

    APOE-mediated sex differences in microvascular pathology and AD-associated proteinopathies in the medial temporal lobe

    Bax F, Oltmer J, Auger CA et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  18. 0.62

    APOE4 and cognition in intracranial atherosclerosis: beyond Alzheimer's pathology

    Cheng A, Zou Y, Liu L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  19. 0.60

    Spatial patterns of tau accumulation across the Alzheimer's disease spectrum

    Fonseca CS, Chao Y, La Joie R et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  20. 0.60

    APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease

    Fortea J, Pegueroles J, Alcolea D et al. · Nature medicine · 2024

  21. 0.60

    Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and APOE alleles

    Loika Y, Webster S, Loiko E et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  22. 0.59

    Initial levels of beta-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer's disease

    Cai Y, Du J, Li A et al. · Alzheimer's research & therapy · 2023

  23. 0.59

    Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts

    Lagarde J, Maiti P, Schonhaut DR et al. · Annals of neurology · 2025

  24. 0.59

    Factors associated with age at tau pathology onset and time from tau onset to dementia in Alzheimer's disease

    Heston MB, Teague JP, Cody KA et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  25. 0.58

    Quantifying natural amyloid plaque accumulation in the continuum of Alzheimer's disease using ADNI

    Elhefnawy ME, Patson N, Mouksassi S et al. · Journal of pharmacokinetics and pharmacodynamics · 2025

  26. 0.58

    Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease

    Ali M, Archer DB, Gorijala P et al. · Acta neuropathologica communications · 2023

  27. 0.53

    Sex and APOE epsilon4 genotype modify risk factor associations with cerebral amyloid angiopathy: a multi-cohort autopsy study

    Ma L, Wang Y, Goudey B et al. · Alzheimer's research & therapy · 2026

  28. 0.52

    Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease Using PET and Plasma Biomarkers

    Brown CA, Cousins KAQ, Korecka M et al. · Annals of neurology · 2026

  29. 0.52

    Determining the Role of Sex and APOE4 status on Psychosis in Alzheimer's Disease

    Fan J, Churchill N, Fadhel A et al. · Journal of geriatric psychiatry and neurology · 2025

  30. 0.51

    beta-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies

    Diaz-Galvan P, Przybelski SA, Lesnick TG et al. · Neurology · 2023

  31. 0.51

    Trajectories of amyloid beta accumulation - Unveiling the relationship with APOE genotype and cognitive decline

    Wybitul M, Buchmann A, Langer N et al. · Neurobiology of aging · 2024

  32. 0.50

    Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-beta and tau - a prospective cohort study

    Glans I, Mattsson-Carlgren N, Strandberg O et al. · The journal of prevention of Alzheimer's disease · 2026

04cox · hazard25편

  1. 0.91

    APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry

    Belloy ME, Andrews SJ, Le Guen Y et al. · JAMA neurology · 2023

  2. 0.90

    Sex variation in the relationship between APOE epsilon4, cognitive decline, and dementia

    Kerr EM, Ailshire JA, Crimmins E et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2025

  3. 0.85

    Age at natural menopause, reproductive lifespan and Alzheimer's disease in females: is APOE epsilon4 the missing link?

    Bruno F, Spadafora P, Abondio P et al. · Frontiers in genetics · 2026

  4. 0.84

    Heterogeneity in the association between APOE epsilon4 carrier status and dementia risk by modifiable and non-modifiable risk factors

    Zhang M, Ho FK, Pell JP et al. · GeroScience · 2026

  5. 0.81

    Incidence of dementia after age 90 years and association with APOE genotype, race, and sex in the USA: the LifeAfter90 prospective cohort study

    Colbeth HL, Corrada MM, Mungas D et al. · The lancet. Healthy longevity · 2026

  6. 0.78

    Multisystem failure, tipping points, and risk of Alzheimer's disease

    Merlini S, Bedrick EJ, Brinton RD et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  7. 0.74

    Plant-based dietary patterns and the risk of dementia: a population-based study

    de Crom TOE, Steur M, Ikram MK et al. · Age and ageing · 2023

  8. 0.73

    ApoE Genotype, Age, and Cognitive Decline in Old Chinese Individuals Without Dementia: A Population-Based Study With Five-Year Follow-Up

    Wu H, Gu X, Liu S et al. · International journal of geriatric psychiatry · 2025

  9. 0.73

    Comorbidity sequence, sex, and APOE-genotype forecast Alzheimer's disease diagnosis

    Merlini S, Gatta R, Orini S et al. · Frontiers in medicine · 2026

  10. 0.72

    Sex differences in the association of vascular risk and APOE Genotype with cognitive decline and dementia: evidence from a U.S. longitudinal study

    Liu L, Hou J, Cui S et al. · Lancet regional health. Americas · 2026

  11. 0.67

    Markers of olfactory dysfunction and progression to dementia: A 12-year population-based study

    Laukka EJ, Ekstrom I, Larsson M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  12. 0.66

    Estimation of events in cohort studies based on probability of cognitive impairment

    Park J, Abner EL, Wang P et al. · Journal of Alzheimer's disease : JAD · 2025

  13. 0.61

    Predicting Preclinical Cognitive Decline Using Plasma P-tau217 and APOE Genotype in 8,582 Individuals From Different Ethnic Groups

    Xu Y, Gunasekaran TI, Gu Y et al. · medRxiv : the preprint server for health sciences · 2026

  14. 0.58

    Walking pace, handgrip strength, age, APOE genotypes, and new-onset dementia: the UK Biobank prospective cohort study

    He P, Zhou C, Ye Z et al. · Alzheimer's research & therapy · 2023

  15. 0.57

    Sepsis increases the risk of dementia in middle-aged and elderly adults: a large prospective cohort study

    Liu J, Fei Y, Wang E et al. · Journal of affective disorders · 2025

  16. 0.57

    Plasma Phosphorylated Tau 217 and Incident Mild Cognitive Impairment and Dementia in Older Women

    Shadyab AH, Zhang B, LaCroix AZ et al. · JAMA network open · 2026

  17. 0.56

    Improved polygenic risk prediction for alzheimer's disease and related dementias using deep learning: age and APOE-stratified analysis

    Mostafaei S, Shemer DW, Mak JKL et al. · Alzheimer's research & therapy · 2026

  18. 0.54

    ABCA7 deletion lowers age at onset of Alzheimer's disease and interacts with APOE epsilon4 synergistically in African-ancestry populations

    Akgun B, Gulyayev AV, Coker M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  19. 0.53

    Searching for responders to multidomain dementia prevention in late life: A pooled analysis of individual participant data from the MAPT and preDIVA trials

    Coley N, Hoevenaar-Blom MP, Shourick J et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  20. 0.52

    Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status

    Ghahremani M, Smith EE, Chen HY et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2023

  21. 0.51

    Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident Dementia

    Smith JR, Pike JR, Gottesman RF et al. · JAMA neurology · 2025

  22. 0.50

    Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium

    Larsen FK, Baksh RA, McGlinchey E et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  23. 0.50

    Specification curve analysis to identify heterogeneity in risk factors for dementia: findings from the UK Biobank

    Luo R, Zeraatkar D, Glymour M et al. · BMC medicine · 2024

  24. 0.50

    Polygenic Propensity for Longevity, APOE-epsilon4 Status, Dementia Diagnosis, and Risk for Cause-Specific Mortality: A Large Population-Based Longitudinal Study of Older Adults

    Ajnakina O, Shamsutdinova D, Stahl D et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2023

  25. 0.50

    Metabolomic ageing (MileAge) in mid-life predicts incident vascular, unspecified and all-cause dementia

    Mutz J, Gilchrist L, Pain O et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

05mice · apoe421편

  1. 0.81

    APOE genotype and sex modulate Alzheimer's disease pathology in aged EFAD transgenic mice

    Balu D, Valencia-Olvera AC, Islam Z et al. · Frontiers in aging neuroscience · 2023

  2. 0.80

    Accelerated midlife endocrine and bioenergetic brain aging in APOE4 females

    Wang T, Mao Z, Shang Y et al. · Frontiers in aging neuroscience · 2025

  3. 0.75

    APOE epsilon4 allele drives female-specific Alzheimer's disease progression via vascular dysfunction and tau spreading

    Huang S, Wu J, He L · Frontiers in neuroscience · 2025

  4. 0.72

    Sex-dependent APOE4 neutrophil-microglia interactions drive cognitive impairment in Alzheimer's disease

    Rosenzweig N, Kleemann KL, Rust T et al. · Nature medicine · 2024

  5. 0.71

    Sex-specific APOE4-dependent innate immunity regulates meningeal lymphatics, brain lipids, neuroinflammation, and cognition

    Delivanoglou N, Todd KT, Almeida F et al. · Neuron · 2026

  6. 0.69

    Effects of obesogenic diet and 17beta-estradiol in female mice with APOE 3/3, 3/4, and 4/4 genotypes

    Christensen A, McGill CJ, Qian W et al. · Frontiers in aging neuroscience · 2024

  7. 0.68

    Identification of female-enriched and disease-associated microglia (FDAMic) contributes to sexual dimorphism in late-onset Alzheimer's disease

    Wu D, Bi X, Chow KHM · Journal of neuroinflammation · 2024

  8. 0.65

    FSH and ApoE4 contribute to Alzheimer's disease-like pathogenesis via C/EBPbeta/delta-secretase in female mice

    Xiong J, Kang SS, Wang M et al. · Nature communications · 2023

  9. 0.64

    Investigating the Effects of APOE Genotype on Intracellular Cholesterol and the Endolysosomal System in the Aging Mouse Brain

    de Leeuw SM, Nuriel T · bioRxiv : the preprint server for biology · 2025

  10. 0.63

    APOE4 accelerates menopause-associated brain metabolic shift and disrupts bioenergetic adaptation

    Wang T, Shang Y, McLean JW et al. · Frontiers in aging neuroscience · 2026

  11. 0.62

    APOE4 negates the effects of ovarian hormones on cerebrovascular endothelial and mitochondrial function

    Kehmeier MN, Famiano A, Cullen AE et al. · The Journal of physiology · 2026

  12. 0.60

    Sex-specific factors and APOEepsilon4 genotype alter functional connectivity at middle age

    Lee BH, McGovern AJ, Lieblich SE et al. · Psychoneuroendocrinology · 2026

  13. 0.60

    APOE4 genotype and old age interact to impact cerebrovascular function, brain volume, and neuroinflammation in mice

    Kehmeier MN, Choi YD, Cullen AE et al. · bioRxiv : the preprint server for biology · 2026

  14. 0.55

    A ketogenic diet improves memory in females in the APOE4 mouse model of Alzheimer's disease

    Di Lucente J, Rutkowsky JM, Errico Provenzano A et al. · GeroScience · 2026

  15. 0.54

    Cell Type-Specific Structural and Functional Signatures of APOE4, Age and Sex in the Mouse Anterior Olfactory Nucleus

    Hu M, Kershaw A, Brunson S et al. · bioRxiv : the preprint server for biology · 2026

  16. 0.52

    APOE4 rat model of Alzheimer's disease: sex differences, genetic risk and diet

    Colarusso B, Ortiz R, Yeboah J et al. · BMC neuroscience · 2024

  17. 0.52

    APOE4 genotype negates the benefits of 17beta-estradiol on cerebrovascular endothelial and mitochondrial function

    Kehmeier MN, Famiano A, Cullen AE et al. · bioRxiv : the preprint server for biology · 2025

  18. 0.51

    APOE epsilon4 disrupts neuronal and network-level function in the anterior olfactory nucleus: Influence of age and sex

    Uzun C, Li Y, Liu S · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  19. 0.51

    Age, sex, and apolipoprotein E isoform alter contextual fear learning, neuronal activation, and baseline DNA damage in the hippocampus

    Boutros SW, Zimmerman B, Nagy SC et al. · Molecular psychiatry · 2023

  20. 0.51

    Sex differences in cognition, anxiety-phenotype and therapeutic effect of metformin in the aged apoE-TR mice

    Lin Y, Luo X, Wang F et al. · Biology of sex differences · 2025

  21. 0.50

    A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice

    Balu D, Valencia-Olvera AC, Nguyen A et al. · Alzheimer's research & therapy · 2023

06biomarkers · plasma13편

  1. 0.86

    Differential Associations of APOEvarepsilon2 and APOEvarepsilon4 Genotypes with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Individuals Without Dementia

    Zhao B, Ou YN, Zhang XY et al. · Journal of Alzheimer's disease : JAD · 2023

  2. 0.80

    Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer's disease

    Biel D, Suarez-Calvet M, Dewenter A et al. · EMBO molecular medicine · 2025

  3. 0.78

    Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome

    Iulita MF, Bejanin A, Vilaplana E et al. · Brain communications · 2023

  4. 0.78

    Sex Differences in Apolipoprotein E and Alzheimer Disease Pathology Across Ancestries

    Xu X, Kwon J, Yan R et al. · JAMA network open · 2025

  5. 0.73

    Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years

    Stocker H, Trares K, Beyer L et al. · Alzheimer's research & therapy · 2023

  6. 0.69

    Higher CSF sTREM2 attenuates APOE epsilon4-related risk for amyloid pathology in cognitively intact adults: The CABLE study

    Wang YC, Huang LY, Guo HH et al. · Journal of neurochemistry · 2025

  7. 0.67

    Blood Biomarkers of Alzheimer Disease and Rates of Global and Domain-Specific Cognitive Decline

    Laukka EJ, Ekstrom I, Valletta M et al. · JAMA network open · 2026

  8. 0.61

    Dietary patterns and blood-based biomarkers of Alzheimer's disease in cognitively intact older adults: Findings from a population-based study

    Mrhar A, Carballo-Casla A, Grande G et al. · The journal of prevention of Alzheimer's disease · 2025

  9. 0.56

    Association of plasma phosphor-tau181 with Abeta levels may vary by APOE epsilon4 status and sex among non-demented old adults

    Cai Y, Fu P, Zhang X · Neuroscience letters · 2023

  10. 0.54

    Temporal Changes in Alzheimer's Disease-Related Biomarkers in the CSF of Cognitively Normal Subjects at Different Ages: The Chongqing Ageing and Dementia Study

    Li WW, Fan DY, Sun Q et al. · Aging cell · 2025

  11. 0.53

    Effects of a 24-week resistance exercise program on brain amyloid and Alzheimer's disease blood-based biomarkers: the AGUEDA randomized controlled trial

    Solis-Urra P, Olvera-Rojas M, Garcia-Rivero Y et al. · medRxiv : the preprint server for health sciences · 2026

  12. 0.51

    Relationships between blood pressure indicators and fluid biomarkers of brain aging in functionally intact older adults

    VandeBunte AM, Ortiz BL, Paolillo EW et al. · Alzheimer's research & therapy · 2025

  13. 0.50

    Alzheimer's blood-based biomarkers, incident dementia, and interactions with age, APOE status, and hormone therapy

    Mielke MM, Gaussoin SA, Casanova R et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

07mild cognitive · mci11편

  1. 0.89

    Disentangling sex-dependent effects of APOE on diverse trajectories of cognitive decline in Alzheimer's disease

    Ma H, Shi Z, Kim M et al. · NeuroImage · 2024

  2. 0.84

    Sex-specific effects of apolipoprotein E epsilon4 genotype on longitudinal hippocampal atrophy in amnestic mild cognitive impairment over a 2-year evaluation period

    Park CH, Lee H, Lee YM et al. · Journal of Alzheimer's disease : JAD · 2025

  3. 0.82

    Modeling the age-specific incidence of mild cognitive impairment incorporating the time-varying relationship of Alzheimer's disease biomarkers over 28 years

    Wang K, Zhu Y, Albert M et al. · Journal of Alzheimer's disease : JAD · 2026

  4. 0.70

    Association of Circulating Caprylic Acid with Risk of Mild Cognitive Impairment and Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort

    Fan L, Zhu X, Borenstein AR et al. · The journal of prevention of Alzheimer's disease · 2023

  5. 0.68

    Longitudinal progression of choroid plexus enlargement is associated with female sex, cognitive decline and ApoE E4 homozygote status

    Novakova Martinkova J, Ferretti MT, Ferrari A et al. · Frontiers in psychiatry · 2023

  6. 0.67

    Sex- and APOE Genotype-Dependent Pain Susceptibility and Alzheimer's Risk Mediated by the Lipid Metabolism Enzyme LPCAT2

    Lai RH, Chung RH, Pai WY et al. · Aging cell · 2025

  7. 0.63

    Towards the development of a management protocol for subjective cognitive decline: Insights from a cross-sectional and longitudinal analysis of multimodal data from a memory clinic

    Mazzeo S, Lassi M, Padiglioni S et al. · Journal of Alzheimer's disease : JAD · 2026

  8. 0.62

    Combination therapy targeting Alzheimer's disease risk factors is associated with a significant delay in Alzheimer's disease-related cognitive decline

    Shang Y, Torrandell-Haro G, Vitali F et al. · Alzheimer's & dementia (New York, N. Y.) · 2025

  9. 0.61

    Cerebrospinal Fluid Alzheimer's Disease Biomarker Patterns of Change Prior to the Onset of Mild Cognitive Impairment

    Sun Y, Moghekar A, Soldan A et al. · Journal of Alzheimer's disease : JAD · 2023

  10. 0.58

    Cerebrospinal fluid proteomic signatures in cognitively normal individuals identify distinct clusters linked to neurodegeneration

    Seo D, Do AN, Heo G et al. · Nature aging · 2025

  11. 0.52

    Integrating Plasma pTau-217 and Digital Cognitive Assessments for Early Detection in Alzheimer's Disease

    Vanderlip CR, Stark CEL · medRxiv : the preprint server for health sciences · 2025

08review · genetic11편

  1. 0.81

    APOE-associated disease risk and sex-specific effects in Egyptian Alzheimer's disease: an exploratory study

    Othman M, Khedr E, Heikal S et al. · Alzheimer's & dementia (New York, N. Y.) · 2026

  2. 0.77

    Sex- and APOE-specific genetic risk factors for late-onset Alzheimer's disease: Evidence from gene-gene interaction of longevity-related loci

    Dato S, De Rango F, Crocco P et al. · Aging cell · 2023

  3. 0.73

    Genome-wide association studies of Alzheimer's disease and related disorders stratified by sex, onset age, and Apolipoprotein E genotype reveal novel risk loci in African Americans

    Sherva R, Zhu C, Zhang R et al. · Alzheimer's research & therapy · 2025

  4. 0.67

    The paired immunoglobulin-like type 2 receptor alpha (PILRA) gene polymorphism rs1859788 reduces risk of Alzheimer's Disease in men homozygous for the ApoE epsilon4 allele

    Lehrer S, Rheinstein P · Research square · 2024

  5. 0.61

    Understanding Alzheimer's disease in the context of aging: Findings from applications of stochastic process models to the Health and Retirement Study

    Arbeev KG, Bagley O, Yashkin AP et al. · Mechanisms of ageing and development · 2023

  6. 0.59

    Sex- and APOE-specific transcriptomic drug repurposing identifies four candidate therapeutics for Alzheimer's disease

    Vitali F, Raikes AC, Merlini S et al. · Alzheimer's & dementia (New York, N. Y.) · 2026

  7. 0.58

    Testosterone as a mediator of APOE4-linked sex differences in Alzheimer's disease

    Shi Z, Wu L, Zhang C et al. · International immunopharmacology · 2025

  8. 0.57

    Uncovering Diverse Mechanistic Spreading Pathways in Disease Progression of Alzheimer's Disease

    Yu Z, Shi Z, Dan T et al. · Journal of Alzheimer's disease reports · 2023

  9. 0.55

    Unveiling the link between APOE epsilon4, environmental factors, and Alzheimer's disease in North Lebanon: A case-control study

    Khaled M, Al-Jamal H, Matar D et al. · Journal of Alzheimer's disease : JAD · 2025

  10. 0.53

    Cognitive Resilience in Apolipoprotein epsilon4 Carrier Women Predicted by Neuron-Derived Extracellular Vesicles

    Manolopoulos A, Mustapic M, Nogueras-Ortiz C et al. · Annals of clinical and translational neurology · 2025

  11. 0.50

    Genome-wide association study and pathway analysis of healthy aging in Super Seniors

    Hoque R, Leach S, Brooks-Wilson A · GeroScience · 2026